232 related articles for article (PubMed ID: 18422886)
1. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.
Fernández-San Millán A; Ortigosa SM; Hervás-Stubbs S; Corral-Martínez P; Seguí-Simarro JM; Gaétan J; Coursaget P; Veramendi J
Plant Biotechnol J; 2008 Jun; 6(5):427-41. PubMed ID: 18422886
[TBL] [Abstract][Full Text] [Related]
2. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.
Liu HL; Li WS; Lei T; Zheng J; Zhang Z; Yan XF; Wang ZZ; Wang YL; Si LS
Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):153-8. PubMed ID: 15756416
[TBL] [Abstract][Full Text] [Related]
3. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
[TBL] [Abstract][Full Text] [Related]
4. Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.
Lenzi P; Scotti N; Alagna F; Tornesello ML; Pompa A; Vitale A; De Stradis A; Monti L; Grillo S; Buonaguro FM; Maliga P; Cardi T
Transgenic Res; 2008 Dec; 17(6):1091-102. PubMed ID: 18491213
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods.
Matić S; Masenga V; Poli A; Rinaldi R; Milne RG; Vecchiati M; Noris E
Plant Biotechnol J; 2012 May; 10(4):410-21. PubMed ID: 22260326
[TBL] [Abstract][Full Text] [Related]
6. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
[TBL] [Abstract][Full Text] [Related]
7. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
8. Transgenic chloroplasts are efficient sites for high-yield production of the vaccinia virus envelope protein A27L in plant cellsdagger.
Rigano MM; Manna C; Giulini A; Pedrazzini E; Capobianchi M; Castilletti C; Di Caro A; Ippolito G; Beggio P; De Giuli Morghen C; Monti L; Vitale A; Cardi T
Plant Biotechnol J; 2009 Aug; 7(6):577-91. PubMed ID: 19508274
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
Yang Y; Li X; Yang H; Qian Y; Zhang Y; Fang R; Chen X
Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033
[TBL] [Abstract][Full Text] [Related]
10. [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli].
Xie M; Li S; Shen W; Li Z; Zhuang Y; Mo X; Gu Y; Wu T; Zhang J; Xia N
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1082-7. PubMed ID: 19835152
[TBL] [Abstract][Full Text] [Related]
11. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.
Mossadegh N; Gissmann L; Müller M; Zentgraf H; Alonso A; Tomakidi P
Virology; 2004 Aug; 326(1):57-66. PubMed ID: 15262495
[TBL] [Abstract][Full Text] [Related]
12. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.
Cook JC; Joyce JG; George HA; Schultz LD; Hurni WM; Jansen KU; Hepler RW; Ip C; Lowe RS; Keller PM; Lehman ED
Protein Expr Purif; 1999 Dec; 17(3):477-84. PubMed ID: 10600468
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.
Pineo CB; Hitzeroth II; Rybicki EP
Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054
[TBL] [Abstract][Full Text] [Related]
14. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
15. Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.
Waheed MT; Thönes N; Müller M; Hassan SW; Razavi NM; Lössl E; Kaul HP; Lössl AG
Transgenic Res; 2011 Apr; 20(2):271-82. PubMed ID: 20563641
[TBL] [Abstract][Full Text] [Related]
16. Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes.
Waheed MT; Thönes N; Müller M; Hassan SW; Gottschamel J; Lössl E; Kaul HP; Lössl AG
Plant Biotechnol J; 2011 Aug; 9(6):651-60. PubMed ID: 21447051
[TBL] [Abstract][Full Text] [Related]
17. Production of human papillomavirus type 16 virus-like particles in transgenic plants.
Biemelt S; Sonnewald U; Galmbacher P; Willmitzer L; Müller M
J Virol; 2003 Sep; 77(17):9211-20. PubMed ID: 12915537
[TBL] [Abstract][Full Text] [Related]
18. Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.
Stanley M; Lowy DR; Frazer I
Vaccine; 2006 Aug; 24 Suppl 3():S3/106-13. PubMed ID: 16949996
[TBL] [Abstract][Full Text] [Related]
19. [Immunogenicity study of HPV 6b virus-like particles].
Liu Y; Liu X; Frazer IH
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476
[TBL] [Abstract][Full Text] [Related]
20. Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.
Roth SD; Sapp M; Streeck RE; Selinka HC
Virol J; 2006 Oct; 3():83. PubMed ID: 17014700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
